Lupus

West Hills-based ImmPACT Bio USA Inc. a clinical-stage company developing chimeric antigen receptor T-cell therapies for treating cancer and autoimmune diseases, has received fast-track designation from the Food and Drug Administration for its leading drug to treat specific types of lupus. Fast-track designation is designed to help drugs reach patients faster by facilitating the development and […]